{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:35:45Z","timestamp":1793367345893,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007471","name":"Northern Borders University","doi-asserted-by":"publisher","award":["NBU- FPEJ-2024-2043-01"],"award-info":[{"award-number":["NBU- FPEJ-2024-2043-01"]}],"id":[{"id":"10.13039\/501100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.arr.2024.102386","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T02:36:00Z","timestamp":1720060560000},"page":"102386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits"],"prefix":"10.1016","volume":"100","author":[{"given":"Saurabh Kumar","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Kumar","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punna Rao","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Prasad","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitikela P.","family":"Pullaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohana Vamsi","family":"Nuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehnaz","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saijyothi","family":"Ausali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosleh Mohammad","family":"Abomughaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Deka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingal","family":"Pritam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harishankar","family":"Shyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrakant K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindhy Wasini","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Dewanjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seid Mahdi","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102386_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.arr.2024.102386_bib2","first-page":"98","article-title":"Medical cannabis in the treatment of Parkinson's disease","volume":"46","author":"Aladeen","year":"2023","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib3","first-page":"10","article-title":"Cannabidiol inhibits Tau aggregation in vitro","author":"Alali","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.arr.2024.102386_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.arr.2024.102386_bib5","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3389\/fimmu.2018.02379","article-title":"Pattern recognition receptors and the host cell death molecular machinery","volume":"9","author":"Amarante-Mendes","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2024.102386_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000519534","article-title":"The effect of cannabidiol coated by nano-chitosan on learning and memory, hippocampal CB1 and CB2 levels, and amyloid plaques in an Alzheimer's disease rat model","volume":"81","author":"Amini","year":"2022","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.arr.2024.102386_bib7","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/acs.molpharmaceut.8b01344","article-title":"Cannabidiol enhances the passage of lipid nanocapsules across the blood-brain barrier both in vitro and in vivo","volume":"16","author":"Aparicio-Blanco","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2024.102386_bib8","doi-asserted-by":"crossref","DOI":"10.1089\/can.2023.0101","article-title":"Effects of chronic, low-dose cannabinoids, cannabidiol, delta-9-tetrahydrocannabinol and a combination of both, on amyloid pathology in the 5xFAD mouse model of Alzheimer's disease","author":"Arnanz","year":"2023","journal-title":"Cannabis cannabinoid Res."},{"key":"10.1016\/j.arr.2024.102386_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington's disease","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102386_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.euroneuro.2010.06.007","article-title":"Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype","volume":"21","author":"Aso","year":"2011","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib11","volume":"16","author":"Assadpour","year":"2023"},{"key":"10.1016\/j.arr.2024.102386_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2045125312457586","article-title":"Cannabis, a complex plant: different compounds and different effects on individuals","volume":"2","author":"Atakan","year":"2012","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","article-title":"Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target","volume":"1762","author":"Barber","year":"2006","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.arr.2024.102386_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34759-z","article-title":"Aggregated SOD1 causes selective death of cultured human motor neurons","volume":"8","author":"Benkler","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102386_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.arr.2024.102386_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.989717","article-title":"Cannabidiol for neurodegenerative disorders: a comprehensive review","volume":"13","author":"Bhunia","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurother.: J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.arr.2024.102386_bib19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/can.2023.0086","article-title":"Effects of the acute and chronic administration of cannabidiol on cognition in humans and animals: a systematic review","volume":"8","author":"Bomfim","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.arr.2024.102386_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111196","article-title":"Aggregation of the protein TRIOBP-1 and its potential relevance to schizophrenia","volume":"9","author":"Bradshaw","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2024.102386_bib21","article-title":"Comprehensive review on Alzheimer's disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Mol. (Basel, Switz.)"},{"key":"10.1016\/j.arr.2024.102386_bib22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1289\/ehp.7567","article-title":"Neurodegenerative diseases: an overview of environmental risk factors","volume":"113","author":"Brown","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.arr.2024.102386_bib23","first-page":"519","article-title":"SOD1 function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes","volume":"21","author":"Bunton-Stasyshyn","year":"2015","journal-title":"Neurosci.: Rev. J. Bringing Neurobiol.\u00a0Neurol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102386_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-016-1621-6","article-title":"Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"133","author":"Cantoni","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102386_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphar.2020.00124","article-title":"From cannabis sativa to cannabidiol: promising therapeutic candidate for the treatment of neurodegenerative diseases","volume":"11","author":"Cassano","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib26","article-title":"The polypharmacological effects of cannabidiol","volume":"28","author":"Castillo-Arellano","year":"2023","journal-title":"Mol. (Basel, Switz.)"},{"key":"10.1016\/j.arr.2024.102386_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.pbr.2020.02.003","article-title":"Animal models for preclinical Parkinson's research: An update and critical appraisal","volume":"252","author":"Cenci","year":"2020","journal-title":"Prog. brain Res."},{"key":"10.1016\/j.arr.2024.102386_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.mehy.2004.11.038","article-title":"Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease","volume":"64","author":"Ceru","year":"2005","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.arr.2024.102386_bib29","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u2206E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.arr.2024.102386_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239036","article-title":"Danger-sensing\/patten recognition receptors and neuroinflammation in Alzheimer's Disease","volume":"21","author":"Chiarini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020325","article-title":"Polyglutamine-expanded androgen receptor alteration of skeletal muscle homeostasis and myonuclear aggregation are affected by sex, age and muscle metabolism","volume":"9","author":"Chivet","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.arr.2024.102386_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12701\/yujm.2018.35.1.1","article-title":"Beta-amyloid imaging in dementia","volume":"35","author":"Chun","year":"2018","journal-title":"Yeungnam Univ. J. Med."},{"key":"10.1016\/j.arr.2024.102386_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310809","article-title":"Unraveling molecular and genetic insights into neurodegenerative diseases: advances in understanding Alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis","volume":"24","author":"Ciurea","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington's disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacol.\u00a0Biochem.\u00a0Behav."},{"key":"10.1016\/j.arr.2024.102386_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/can.2018.0006","article-title":"A cross-sectional study of cannabidiol users","volume":"3","author":"Corroon","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.arr.2024.102386_bib36","first-page":"2390","article-title":"Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or \u03b1-synuclein in Caenorhabditis elegans","volume":"48","author":"da Cruz Guedes","year":"2023"},{"key":"10.1016\/j.arr.2024.102386_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1096\/fj.201601184","article-title":"Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain","volume":"31","author":"Currais","year":"2017","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.arr.2024.102386_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fneur.2014.00251","article-title":"Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients","volume":"5","author":"David","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2024.102386_bib39","first-page":"504","article-title":"Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"P T: a peer-Rev. J. Formul. Manag."},{"key":"10.1016\/j.arr.2024.102386_bib40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/epi.14628","article-title":"Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial","volume":"60","author":"Devinsky","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.arr.2024.102386_bib41","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mdc3.13754","article-title":"A Phase Ib, Double Blind, Randomized Study of Cannabis Oil for Pain in Parkinson's Disease","volume":"10","author":"Di Luca","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.arr.2024.102386_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.952161","article-title":"Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019","volume":"10","author":"Ding","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.arr.2024.102386_bib43","doi-asserted-by":"crossref","first-page":"C581","DOI":"10.1152\/ajpcell.00005.2022","article-title":"Exercise mitigates the Toll of muscle atrophy: a narrative review of the effects of exercise on Toll-like receptor-4 in leukocytes and skeletal muscle","volume":"322","author":"Ducharme","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.arr.2024.102386_bib44","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of Neurodegenerative Diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2024.102386_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol., Biochem., Behav."},{"key":"10.1016\/j.arr.2024.102386_bib46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1177\/1352458518814117","article-title":"Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","volume":"25","author":"Elliott","year":"2019","journal-title":"Mult. Scler. (Houndmills, Basingstoke, Engl. )"},{"key":"10.1016\/j.arr.2024.102386_bib47","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/npp.2010.32","article-title":"Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology","volume":"35","author":"Escribano","year":"2010","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med. (Berl., Ger. )"},{"key":"10.1016\/j.arr.2024.102386_bib49","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib50","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00213-011-2449-3","article-title":"Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders","volume":"219","author":"Fagherazzi","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.arr.2024.102386_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib52","first-page":"551","article-title":"Upregulation of CB(2) receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis","volume":"10","author":"Fern\u00e1ndez-Trapero","year":"2017","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.arr.2024.102386_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1094020","article-title":"Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: a review","volume":"14","author":"Fu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib54","article-title":"Cannabidiol attenuates cognitive deficits and neuroinflammation induced by early alcohol exposure in a mice model","volume":"141","author":"Garc\u00eda-Baos","year":"2021","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"10.1016\/j.arr.2024.102386_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111575","article-title":"Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders","volume":"10","author":"Garc\u00eda-Guti\u00e9rrez","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102386_bib56","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3897\/folmed.65.e107259","article-title":"Cannabidiol improves memory and decreases IL-1\u03b2 serum levels in rats with lipopolysaccharide-induced inflammation","volume":"65","author":"Georgieva-Kotetarova","year":"2023","journal-title":"Folia Med."},{"key":"10.1016\/j.arr.2024.102386_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.msard.2017.06.015","article-title":"Sativex in the management of multiple sclerosis-related spasticity: an overview of the last decade of clinical evaluation","volume":"17","author":"Giacoppo","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102386_bib58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40478-014-0176-9","article-title":"Models of \u03b1-synuclein aggregation in Parkinson's disease","volume":"2","author":"Gir\u00e1ldez-P\u00e9rez","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102386_bib59","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102386_bib60","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson's disease with the alpha-synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1684\/epd.2020.1135","article-title":"The proposed mechanisms of action of CBD in epilepsy","volume":"22","author":"Gray","year":"2020","journal-title":"Epileptic Disord.: Int. Epilepsy J. Videotape"},{"key":"10.1016\/j.arr.2024.102386_bib62","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14728214.2011.604312","article-title":"Emerging drugs for amyotrophic lateral sclerosis","volume":"16","author":"Habib","year":"2011","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.arr.2024.102386_bib63","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvp240","article-title":"CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages","volume":"84","author":"Han","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2024.102386_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00406-019-01068-z","article-title":"Cannabis use and psychosis: a review of reviews","volume":"270","author":"Hasan","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.arr.2024.102386_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914514","article-title":"Current challenges and opportunities for improved cannabidiol solubility","volume":"24","author":"Hossain","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102386_bib67","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0269881117737400","article-title":"The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group","volume":"32","author":"Hundal","year":"2018","journal-title":"J. Psychopharmacol. (Oxf., Engl. )"},{"key":"10.1016\/j.arr.2024.102386_bib68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fphar.2020.00261","article-title":"Pharmacotherapy of Alzheimer's disease: seeking clarity in a time of uncertainty","volume":"11","author":"Husna Ibrahim","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib69","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurother.: J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.arr.2024.102386_bib70","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102386_bib71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: a critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.arr.2024.102386_bib72","article-title":"Unveiling the impact of Aging on BBB and Alzheimer's disease: factors and Therapeutic implications","author":"Jha","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102386_bib73","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4103\/1673-5374.272575","article-title":"Targeting the P2X7 receptor in microglial cells to prevent brain inflammation","volume":"15","author":"Jiang","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2024.102386_bib74","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington's disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.arr.2024.102386_bib75","article-title":"A critical review of the role of the cannabinoid compounds \u0394(9)-tetrahydrocannabinol (\u0394(9)-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment","volume":"25","author":"Jones","year":"2020","journal-title":"Mol. (Basel, Switz.)"},{"key":"10.1016\/j.arr.2024.102386_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061432","article-title":"Molecular pathophysiological mechanisms in Huntington's disease","volume":"10","author":"Jurcau","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2024.102386_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.654340","article-title":"Cannabidiol induces autophagy to protects neural cells from mitochondrial dysfunction by upregulating SIRT1 to inhibits NF-\u03baB and NOTCH pathways","volume":"15","author":"Kang","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2024.102386_bib78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0974-8520.100295","article-title":"Drug discovery from plant sources: an integrated approach","volume":"33","author":"Katiyar","year":"2012","journal-title":"Ayu"},{"key":"10.1016\/j.arr.2024.102386_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2015.11.049","article-title":"Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis","volume":"577","author":"Kaur","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.arr.2024.102386_bib80","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2024.102386_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010204","article-title":"Exploring the potential of cannabinoid nanodelivery systems for CNS disorders","volume":"15","author":"Kolesarova","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2024.102386_bib82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnmol.2015.00073","article-title":"Innate immune response in brain, NF-Kappa B signaling and cystatins","volume":"8","author":"Kopitar-Jerala","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102386_bib83","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102386_bib84","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41380-018-0104-7","article-title":"Glutathione and glutamate in schizophrenia: a 7T MRS study","volume":"25","author":"Kumar","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102386_bib85","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neurol.2023.03.018","article-title":"Cannabis for the treatment of amyotrophic lateral sclerosis: what is the patients' view?","volume":"179","author":"Lacroix","year":"2023","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102386_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040514","article-title":"Assessing the safety and therapeutic efficacy of cannabidiol lipid nanoparticles in alleviating metabolic and memory impairments and hippocampal histopathological changes in diabetic Parkinson's Rats","volume":"16","author":"Lapmanee","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2024.102386_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.seizure.2019.04.008","article-title":"Unverricht-Lundborg disease: Clinical course and seizure management based on the experience of polish centers","volume":"69","author":"Lasek-Bal","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.arr.2024.102386_bib88","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1358\/dot.2019.55.3.2909248","article-title":"Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome","volume":"55","author":"Lattanzi","year":"2019","journal-title":"Drugs Today (Barc., Spain.: 1998)"},{"key":"10.1016\/j.arr.2024.102386_bib89","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/can.2019.0068","article-title":"Safety and tolerability of cannabidiol in Parkinson disease: an open label, dose-escalation study","volume":"5","author":"Leehey","year":"2020","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.arr.2024.102386_bib90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2016.03.005","article-title":"Cannabidiol and epilepsy: rationale and therapeutic potential","volume":"107","author":"Leo","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2024.102386_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163896","article-title":"Causative links between protein aggregation and oxidative stress: a review","volume":"20","author":"L\u00e9vy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib92","article-title":"Neuroinflammation in Prion disease","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib93","first-page":"113","article-title":"Cannabidiol-mediated sequestration of Alzheimer\u2019s amyloid-\u03b2 Peptides in ADDL oligomers.","volume":"13","author":"Li","year":"2023"},{"key":"10.1016\/j.arr.2024.102386_bib94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102386_bib95","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00415-016-8145-9","article-title":"A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease","volume":"263","author":"L\u00f3pez-Send\u00f3n Moreno","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102386_bib96","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102386_bib97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12906-016-1280-0","article-title":"Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells","volume":"16","author":"Lukhele","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.arr.2024.102386_bib98","first-page":"8820","article-title":"High dosage of cannabidiol (CBD) alleviates pentylenetetrazole-induced epilepsy in rats by exerting an anticonvulsive effect","volume":"8","author":"Mao","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.arr.2024.102386_bib99","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/sni.sni_45_18","article-title":"Review of the neurological benefits of phytocannabinoids","volume":"9","author":"Maroon","year":"2018","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.arr.2024.102386_bib100","first-page":"3","article-title":"Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review)","volume":"5","author":"Martin","year":"2000","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.arr.2024.102386_bib101","article-title":"Molecular and cellular mechanisms of action of cannabidiol","volume":"28","author":"Martinez Naya","year":"2023","journal-title":"Mol. (Basel, Switz.)"},{"key":"10.1016\/j.arr.2024.102386_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105698","article-title":"Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain","volume":"159","author":"Matarazzo","year":"2021","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib103","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2024.102386_bib104","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: implications in Parkinson's disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. et\u00a0Biophys. Acta Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102386_bib105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12883-019-1443-y","article-title":"Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)","volume":"19","author":"Meyer","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2024.102386_bib106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00441-013-1692-9","article-title":"Leading compounds for the validation of animal models of psychopathology","volume":"354","author":"Micale","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.arr.2024.102386_bib107","doi-asserted-by":"crossref","unstructured":"Micale, V., Ruda-Kucerova, J., Drago, F., Micale, V., Tabiova, Kucerova, Drago, F., 2014. Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence.","DOI":"10.1007\/978-1-4939-2294-9_5"},{"key":"10.1016\/j.arr.2024.102386_bib108","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.xphs.2022.09.012","article-title":"Lipid nano-carriers loaded with Cannabis sativa extract for epilepsy treatment - in vitro characterization and in vivo efficacy studies","volume":"111","author":"Mihailova","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib109","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/cns.12262","article-title":"Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(\u00ae) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis","volume":"20","author":"Moreno-Martet","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2024.102386_bib110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuro.2022.09.001","article-title":"Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and \u03b1-synuclein accumulation in C. elegans models of Parkinson's disease","volume":"93","author":"Muhammad","year":"2022","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.arr.2024.102386_bib111","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000497361","article-title":"Development of a novel nano-emulsion formulation to improve intestinal absorption of cannabidiol","volume":"2","author":"Nakano","year":"2019","journal-title":"Med. Cannabis cannabinoids"},{"key":"10.1016\/j.arr.2024.102386_bib112","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1021\/acs.jmedchem.0c00724","article-title":"The essential medicinal chemistry of cannabidiol (CBD)","volume":"63","author":"Nelson","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2024.102386_bib113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102386_bib114","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094294","article-title":"Cannabidiol in neurological and neoplastic diseases: latest developments on the molecular mechanism of action","volume":"22","author":"O\u017carowski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib116","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.7150\/thno.83066","article-title":"New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)","volume":"13","author":"Palanisamy","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2024.102386_bib117","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11920-019-1026-z","article-title":"Cannabinoid regulation of fear and anxiety: an update","volume":"21","author":"Papagianni","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.arr.2024.102386_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.595635","article-title":"Cannabidiol as a therapeutic target: evidence of its neuroprotective and neuromodulatory function in Parkinson's disease","volume":"11","author":"Patricio","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib119","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.271.5256.1731","article-title":"Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)","volume":"271","author":"Pennacchio","year":"1996","journal-title":"Sci. (N. Y., N. Y. )"},{"key":"10.1016\/j.arr.2024.102386_bib120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/ITT.S263690","article-title":"Cannabidiol as a novel therapeutic for immune modulation","volume":"9","author":"Peyravian","year":"2020","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.arr.2024.102386_bib121","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41398-022-02077-8","article-title":"Plasma amyloid-\u03b2 dynamics in late-life major depression: a longitudinal study","volume":"12","author":"Pomara","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2024.102386_bib122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/14660820310016813","article-title":"Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid","volume":"5","author":"Raman","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord.: Off. Publ. World Fed. Neurol., Res. Group Mot. Neuron Dis."},{"key":"10.1016\/j.arr.2024.102386_bib123","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/ptr.7742","article-title":"Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids","volume":"37","author":"Reddy","year":"2023","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.arr.2024.102386_bib124","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10897-015-9840-x","article-title":"Analysis of the reasons for non-uptake of predictive testing for Huntington's disease in Spain: a qualitative study","volume":"24","author":"Rivera-Navarro","year":"2015","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.arr.2024.102386_bib125","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10 Suppl","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102386_bib126","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102386_bib127","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/138920291501140306113344","article-title":"The mechanistic links between proteasome activity, aging and age-related diseases","volume":"15","author":"Saez","year":"2014","journal-title":"Curr. Genom."},{"key":"10.1016\/j.arr.2024.102386_bib128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JHD-170283","article-title":"Cannabinoids for treatment of dystonia in Huntington's Disease","volume":"7","author":"Saft","year":"2018","journal-title":"J. Huntingt's\u00a0Dis."},{"key":"10.1016\/j.arr.2024.102386_bib129","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2024.102386_bib130","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102386_bib131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","article-title":"Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors","volume":"87","author":"Salminen","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102386_bib132","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","article-title":"Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors","volume":"303","author":"Sartim","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2024.102386_bib133","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0040-2016","article-title":"Toll-like receptor signaling and its inducible proteins","volume":"4","author":"Satoh","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.arr.2024.102386_bib134","article-title":"Cannabidiol and brain function: current knowledge and future perspectives","volume":"14","author":"Schouten","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib135","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.arr.2024.102386_bib136","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40429-020-00326-8","article-title":"Therapeutic efficacy of cannabidiol (CBD): a review of the evidence from clinical trials and human laboratory studies","volume":"7","author":"Sholler","year":"2020","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.arr.2024.102386_bib137","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8825358","article-title":"Emerging therapeutic potential of cannabidiol (CBD) in neurological disorders: a comprehensive review","volume":"2023","author":"Singh","year":"2023","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.arr.2024.102386_bib138","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102386_bib139","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00213-021-05823-w","article-title":"Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study","volume":"238","author":"Spinella","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.arr.2024.102386_bib140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fnmol.2017.00390","article-title":"Amyloid-\u03b2 homeostasis bridges inflammation, synaptic plasticity deficits and cognitive dysfunction in multiple sclerosis","volume":"10","author":"Stampanoni Bassi","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102386_bib141","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","article-title":"Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo","volume":"137","author":"Stancu","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102386_bib142","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/13543784.2020.1743678","article-title":"Epilepsy: key experimental therapeutics in early clinical development","volume":"29","author":"Steriade","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.arr.2024.102386_bib143","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jnnp-2017-317168","article-title":"Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence","volume":"89","author":"Stockings","year":"2018","journal-title":"J. Neurol.\u00a0Neurosurg.\u00a0Psychiatry"},{"key":"10.1016\/j.arr.2024.102386_bib144","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fncel.2015.00336","article-title":"SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis","volume":"9","author":"Tafuri","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2024.102386_bib145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/epi.17150","article-title":"Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: an open-label extension trial","volume":"63","author":"Thiele","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.arr.2024.102386_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061578","article-title":"Natural products for drug discovery in the 21st century: innovations for novel drug discovery","volume":"19","author":"Thomford","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib147","doi-asserted-by":"crossref","unstructured":"Tsai, R.M., Boxer, A.L.J.C.t.o.i.n., 2014. Treatment of frontotemporal dementia. 16, 1-14..","DOI":"10.1007\/s11940-014-0319-0"},{"key":"10.1016\/j.arr.2024.102386_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040684","article-title":"Effects of a sativex-like combination of phytocannabinoids on disease progression in R6\/2 mice, an experimental model of Huntington's disease","volume":"18","author":"Valdeolivas","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102386_bib149","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/abbs\/gmx073","article-title":"Effects of cannabidiol interactions with Wnt\/\u03b2-catenin pathway and PPAR\u03b3 on oxidative stress and neuroinflammation in Alzheimer's disease.","volume":"49","author":"Vall\u00e9e","year":"2017","journal-title":"Acta Biochim. et\u00a0Biophys. Sin."},{"key":"10.1016\/j.arr.2024.102386_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051709","article-title":"Advances in neurodegenerative diseases","volume":"12","author":"Van Schependom","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2024.102386_bib151","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000527335","article-title":"Cannabis sativa and cannabidiol: a therapeutic strategy for the treatment of neurodegenerative diseases?","volume":"5","author":"Viana","year":"2022","journal-title":"Med. Cannabis Cannabinoids"},{"key":"10.1016\/j.arr.2024.102386_bib152","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1111\/bph.14380","article-title":"Effects of cannabidiol plus naltrexone on motivation and ethanol consumption","volume":"175","author":"Viudez-Mart\u00ednez","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib153","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol.\u00a0Biochem.\u00a0Behav."},{"key":"10.1016\/j.arr.2024.102386_bib154","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1038\/s41598-021-84879-2","article-title":"Cannabidiol induces autophagy via ERK1\/2 activation in neural cells","volume":"11","author":"Vrechi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102386_bib155","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult. Scler. (Houndmills, Basingstoke, Engl.)"},{"key":"10.1016\/j.arr.2024.102386_bib156","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102386_bib157","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.2174\/1568026621666211201150217","article-title":"Potential therapeutic strategies of phytochemicals in neurodegenerative disorders","volume":"21","author":"Yadav","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.arr.2024.102386_bib158","article-title":"Role of pollution-induced oxidative stress and inflammation in neurodegenerative diseases, and the mechanisms of traditional Chinese medicine\u2019s potential remediation","volume":"262","author":"Yang","year":"2024","journal-title":"Rev. Environ. Contam. Toxicol."},{"key":"10.1016\/j.arr.2024.102386_bib159","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12974-024-03043-5","article-title":"Parkinson's disease-derived \u03b1-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype","volume":"21","author":"Yildirim-Balatan","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2024.102386_bib160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102386_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/epi4.12934","article-title":"Potassium channel-related epilepsy: pathogenesis and clinical features","author":"Zhao","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.arr.2024.102386_bib162","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/glia.20919","article-title":"Extracellular mutant SOD1 induces microglial-mediated motoneuron injury","volume":"58","author":"Zhao","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.arr.2024.102386_bib163","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724002046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724002046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T04:13:47Z","timestamp":1726632827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724002046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":163,"alternative-id":["S1568163724002046"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102386","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102386"}}